WallStreetZenWallStreetZen

NASDAQ: EIKN
Eikon Therapeutics Inc Stock Ownership - Who owns Eikon Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Eikon Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Column Group IV GP LP10% Owner2026-02-061,437,323$18.00
$25.87MBuy
Column Group IV GP LP10% Owner2026-02-0649,556$18.00
$892.01kBuy
Column Group IV GP LP10% Owner2026-02-06630,881$18.00
$11.36MBuy
Foresite Capital Management IV LLC10% Owner2026-02-0455,555$18.00
$999.99kBuy
Kenneth C. FrazierDirector2026-02-04111,111$18.00
$2.00MBuy
Lux Venture Partners V LLC10% Owner2026-02-04138,888$18.00
$2.50MBuy
Lux Venture Partners V LLC10% Owner2026-02-04138,888$18.00
$2.50MBuy
Josh WolfeDirector2026-02-04138,888$18.00
$2.50MBuy
Josh WolfeDirector2026-02-04138,888$18.00
$2.50MBuy

1 of 1

EIKN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EIKN insiders and whales buy or sell their stock.

EIKN Shareholders

What type of owners hold Eikon Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Column Group IV GP LP10.68%5,783,495$67.96MInsider
Fmr LLC7.09%3,836,830$45.08MInstitution
Blackrock Inc6.13%3,319,379$39.00MInstitution
Lux Venture Partners V LLC4.24%2,294,653$26.96MInsider
Josh Wolfe4.24%2,294,653$26.96MInsider
Foresite Capital Management IV LLC3.59%1,943,682$22.84MInstitution
Merck Co Inc3.08%1,666,666$19.58MInstitution
Roger M. Perlmutter2.73%1,475,856$17.34MInsider
Foresite Capital Management V LLC2.44%1,318,983$15.50MInstitution
Foresite Capital Management IV LLC2.44%1,318,983$15.50MInsider

1 of 3

EIKN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EIKN43.86%24.62%Net Buying
CADL59.27%24.06%Net BuyingNet Buying
SLDB60.19%39.81%Net Selling
CLYM56.39%10.97%Net BuyingNet Selling
ARVN70.18%29.82%Net SellingNet Selling
View Top Biotech Stocks

Eikon Therapeutics Stock Ownership FAQ

Who owns Eikon Therapeutics?

Eikon Therapeutics (NASDAQ: EIKN) is owned by 43.86% institutional shareholders, 24.62% Eikon Therapeutics insiders, and 31.52% retail investors. Column Group IV GP LP is the largest individual Eikon Therapeutics shareholder, owning 5.78M shares representing 10.68% of the company. Column Group IV GP LP's Eikon Therapeutics shares are currently valued at $61.54M.

If you're new to stock investing, here's how to buy Eikon Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.